BDTX
Price
$2.58
Change
-$0.02 (-0.77%)
Updated
Jul 3 closing price
Capitalization
147.84M
39 days until earnings call
CGEN
Price
$1.76
Change
+$0.02 (+1.15%)
Updated
Jul 3 closing price
Capitalization
161.17M
27 days until earnings call
Interact to see
Advertisement

BDTX vs CGEN

Header iconBDTX vs CGEN Comparison
Open Charts BDTX vs CGENBanner chart's image
Black Diamond Therapeutics
Price$2.58
Change-$0.02 (-0.77%)
Volume$472.34K
Capitalization147.84M
Compugen
Price$1.76
Change+$0.02 (+1.15%)
Volume$94.6K
Capitalization161.17M
BDTX vs CGEN Comparison Chart in %
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. CGEN commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a StrongBuy and CGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BDTX: $2.58 vs. CGEN: $1.76)
Brand notoriety: BDTX and CGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 38% vs. CGEN: 42%
Market capitalization -- BDTX: $147.84M vs. CGEN: $161.17M
BDTX [@Biotechnology] is valued at $147.84M. CGEN’s [@Biotechnology] market capitalization is $161.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileCGEN’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • CGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDTX and CGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 3 TA indicator(s) are bullish while CGEN’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 3 bullish, 5 bearish.
  • CGEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а +4.88% price change this week, while CGEN (@Biotechnology) price change was +4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

CGEN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEN($161M) has a higher market cap than BDTX($148M). CGEN has higher P/E ratio than BDTX: CGEN (64.00) vs BDTX (43.33). BDTX YTD gains are higher at: 20.561 vs. CGEN (15.033). BDTX has higher annual earnings (EBITDA): -3.66M vs. CGEN (-14.79M). BDTX has more cash in the bank: 152M vs. CGEN (104M). CGEN has less debt than BDTX: CGEN (2.77M) vs BDTX (21.6M). BDTX has higher revenues than CGEN: BDTX (70M) vs CGEN (27.6M).
BDTXCGENBDTX / CGEN
Capitalization148M161M92%
EBITDA-3.66M-14.79M25%
Gain YTD20.56115.033137%
P/E Ratio43.3364.0068%
Revenue70M27.6M254%
Total Cash152M104M146%
Total Debt21.6M2.77M780%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXCGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVAHF0.08N/A
N/A
EGF THERAMED HEALTH CORP.
GAERF12.49N/A
N/A
Grupo Aeroportuario del Centro Norte S.A.B. de C.V.
MNLXF0.28N/A
N/A
MiniLuxe Holding Corp.
BOIVF6.24-0.04
-0.56%
Bollore Investissement
ASOMY4.11-0.15
-3.63%
ASOS plc

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ATXS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-0.77%
ATXS - BDTX
50%
Loosely correlated
+1.40%
CCCC - BDTX
50%
Loosely correlated
-2.63%
RLAY - BDTX
48%
Loosely correlated
+0.83%
BEAM - BDTX
47%
Loosely correlated
+0.65%
IMNM - BDTX
47%
Loosely correlated
+2.43%
More